Alfred D. Kingsley - Jun 22, 2021 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Stock symbol
LCTX
Transactions as of
Jun 22, 2021
Transactions value $
$135,960
Form type
4
Date filed
6/23/2021, 01:15 PM
Next filing
Jun 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares, no par value Options Exercise $136K +61.8K +1.14% $2.20 5.47M Jun 22, 2021 Direct
holding LCTX Common Shares, no par value 1.04M Jun 22, 2021 By corporation F1
holding LCTX Common Shares, no par value 375K Jun 22, 2021 By LP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Stock Option (right to buy) Options Exercise $0 -61.8K -100% $0.00* 0 Jun 22, 2021 Common Shares 61.8K $2.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
F2 Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.
F3 This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.

Remarks:

Exhibit 24.1 - Substitute Power of Attorney